Learn about our world-class HEOR and curation teams
Vector Oncology provides health economics and outcomes research (HEOR) and real world evidence (RWE) solutions to leading pharmaceutical companies. We design and execute retrospective, multi-year hybrid and synthetic cohort studies and registries enrolling targeted cohorts of patients in active treatment to deliver real time, real world evidence on current and changing treatment patterns, combinations, comparative effectiveness, health outcomes, and economic value. Learn more >>
Precision Health AI and Vector Oncology, both SymphonyAI Companies, Partner to Deliver the Industry’s Best Real World Evidence Oncology Solutions
Pharma, Providers and Payers Can Now Leverage combined Definitive Real World Oncology Data, AI Platform and Leading HEOR Analytics Capabilities. Read the full announcement >>
Oncology focused expertise powered by real world data makes
Vector Oncology the informed choice for US and global research.
Vector Oncology’s HEOR business line, created in 2005, conducts studies involving health outcomes and economic endpoints, including prospective